The same global food system that is fueling rising obesity rates is also accelerating climate change, according to a sweeping ...

CNBC's Annika Kim Constantino reports on Eli Lilly after the company said its closely watched obesity pill helped patients ...

The increase in high cholesterol and obesity cases has put nutrition research on the path of looking for culturally familiar ...

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

NVO files an NDA with the FDA for once-weekly CagriSema, a combo obesity injection showing superior weight loss in obese patients in phase III studies.

Although the injectable forms of the popular GLP-1 drugs are more effective, the pills under development are both easier to ...

This has been a well-established fact: current food culture across the world has much to do with obesity becoming a more and ...

The perception of GLP-1s — and the people who use them — is getting better, but work still must be done to avoid stigma.

The number of US adults living with heart failure has more than doubled over the past three decades, mostly due to the rising ...

Eli Lilly has now submitted a new drug application (NDA) for GLP-1RA orforglipron to the FDA for use in adults with obesity.

GLP-1s improved outcomes in patients with heart failure with preserved ejection fraction, with or without obesity, but those ...

A recent dietary study maps what Indians are eating today and how it is linked to rising diabetes, obesity and prediabetes.